scholarly article | Q13442814 |
P2093 | author name string | Zhang J | |
Rahman S | |||
Corrigall WA | |||
Engleman EA | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dopamine | Q170304 |
nicotine | Q12144 | ||
P304 | page(s) | 415-424 | |
P577 | publication date | 2004-01-01 | |
P1433 | published in | Neuroscience | Q15708571 |
P1476 | title | Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study | |
P478 | volume | 129 |
Q37081416 | A psychobiological framework of the substrates that mediate nicotine use during adolescence |
Q47225379 | Acute and chronic modulation of striatal endocannabinoid-mediated plasticity by nicotine |
Q26996271 | Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction |
Q36797967 | Animal models and treatments for addiction and depression co-morbidity |
Q48649471 | Baclofen prevented the changes in c-Fos and brain-derived neutrophic factor expressions during mecamylamine-precipitated nicotine withdrawal in mice |
Q48139910 | Bifeprunox: a partial agonist at dopamine D2 and serotonin 1A receptors, influences nicotine-seeking behaviour in response to drug-associated stimuli in rats |
Q42516910 | Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. |
Q33616676 | Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose. |
Q45983401 | Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice. |
Q48591704 | Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction |
Q46706771 | Discounting delayed and probabilistic monetary gains and losses by smokers of cigarettes |
Q37821386 | Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse |
Q42682263 | Dopaminergic signaling mediates the motivational response underlying the opponent process to chronic but not acute nicotine |
Q33786352 | Effects of dopamine antagonists on drug cue-induced reinstatement of nicotine-seeking behavior in rats |
Q46882400 | Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study |
Q35892693 | Ethanol and nicotine interaction within the posterior ventral tegmental area in male and female alcohol-preferring rats: evidence of synergy and differential gene activation in the nucleus accumbens shell |
Q42860453 | Exposure to nicotine produces an increase in dopamine D2(High) receptors: a possible mechanism for dopamine hypersensitivity |
Q34359105 | Glutamatergic and GABAergic metabolism in mouse brain under chronic nicotine exposure: implications for addiction |
Q37163861 | Influence of neuronal nicotinic receptors over nicotine addiction and withdrawal |
Q36703862 | Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug |
Q28513200 | Long-term effects of chronic nicotine exposure on brain nicotinic receptors |
Q27687645 | Mechanistic insights into nicotine withdrawal |
Q43117098 | Microdialysis in the rat striatum: effects of 24 h dexamethasone retrodialysis on evoked dopamine release and penetration injury |
Q37508580 | Modeling nicotinic neuromodulation from global functional and network levels to nAChR based mechanisms |
Q91991315 | Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse |
Q28111991 | New mechanisms and perspectives in nicotine withdrawal |
Q28111990 | Nicotine and endogenous opioids: Neurochemical and pharmacological evidence |
Q37525085 | Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction |
Q37760463 | Nicotine: alcohol reward interactions |
Q35142884 | Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus |
Q34359231 | Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system |
Q42488958 | Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration |
Q30494110 | Progressive and lasting amplification of accumbal nicotine-seeking neural signals |
Q42171451 | Regional brain activity correlates of nicotine dependence |
Q34173418 | Reward, addiction, withdrawal to nicotine |
Q35779214 | Shifting pharmacology of nicotine use and withdrawal: breaking the cycle of drug abuse |
Q38345709 | Smoking abstinence and neurocognition: implications for cessation and relapse |
Q34164290 | Spectral confocal imaging of fluorescently tagged nicotinic receptors in knock-in mice with chronic nicotine administration |
Q42709614 | The effects of nicotine and tobacco particulate matter on dopamine uptake in the rat brain |
Q35171303 | The metabotropic glutamate 2/3 receptor agonist LY379268 blocked nicotine-induced increases in nucleus accumbens shell dopamine only in the presence of a nicotine-associated context in rats |
Q36933882 | The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum |
Q41405373 | Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal |
Q36798993 | Varenicline-Induced Elevation of Dopamine in Smokers: A Preliminary [(11)C]-(+)-PHNO PET Study. |
Q43289473 | Voluntary nicotine consumption triggers in vivo potentiation of cortical excitatory drives to midbrain dopaminergic neurons. |
Q35583364 | Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens |
Q36054871 | α3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo |
Q35264378 | α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease |
Search more.